Table of Contents
Table 5-62: Perry
Table 5-64: Porter
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 29 | 448.3 | 153 | 460.1 | 14 | 218.0** | 72 | 225.8 |
| Esophagus | * | # | 3 | # | * | # | 1 | # |
| Stomach | * | # | 3 | # | * | # | 2 | # |
| Colon excluding Rectum | * | # | 11 | 36.1** | * | # | 8 | 29.0** |
| Rectum and Rectosigmoid Junction | * | # | 5 | 14.2** | * | # | 0 | # |
| Liver | * | # | 1 | # | * | # | 1 | # |
| Pancreas | * | # | 7 | 20.7** | * | # | 5 | 14.4** |
| Lung and Bronchus | 6 | 91.9** | 31 | 90.8 | * | # | 31 | 91.8 |
| Melanoma of the Skin | * | # | 4 | # | * | # | 1 | # |
| Prostate | 7 | 105.5** | 36 | 109.0 | * | # | 4 | # |
| Urinary Bladder | * | # | 13 | 39.7** | * | # | 1 | # |
| Kidney and Renal Pelvis | * | # | 13 | 39.6** | * | # | 3 | # |
| Brain and Other Nervous System | * | # | 2 | # | * | # | 1 | # |
| Non-Hodgkin Lymphoma | * | # | 7 | 19.8** | * | # | 3 | # |
| Myeloma | * | # | 0 | # | * | # | 0 | # |
| Leukemia | * | # | 2 | # | * | # | 3 | # |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 36 | 444.5 | 157 | 384.1 | 10 | 107.8** | 66 | 152.0 |
| Colon excluding Rectum | 5 | 51.1** | 16 | 34.6** | * | # | 9 | 21.8** |
| Rectum and Rectosigmoid Junction | * | # | 5 | 11.2** | * | # | 1 | # |
| Liver | * | # | 1 | # | * | # | 3 | # |
| Pancreas | * | # | 5 | 11.9** | * | # | 5 | 12.0** |
| Lung and Bronchus | 5 | 54.1** | 20 | 48.3 | * | # | 11 | 25.8** |
| Melanoma of the Skin | * | # | 1 | # | * | # | 0 | # |
| Breast | 10 | 129.4** | 48 | 124.6 | * | # | 9 | 22.0** |
| Cervix Uteri | * | # | 6 | 14.8** | * | # | 1 | # |
| Corpus Uteri | * | # | 14 | 36.4** | * | # | 1 | # |
| Ovary | * | # | 3 | # | * | # | 0 | # |
| Urinary Bladder | * | # | 4 | # | * | # | 1 | # |
| Kidney and Renal Pelvis | * | # | 2 | # | * | # | 1 | # |
| Brain and Other Nervous System | * | # | 5 | 13.7** | * | # | 3 | # |
| Non-Hodgkin Lymphoma | * | # | 5 | 11.0** | * | # | 4 | # |
| Myeloma | * | # | 2 | # | * | # | 2 | # |
| Leukemia | * | # | 3 | # | * | # | 4 | # |
Rates are per 100,000; Age-adjusted, 2000 U.S. Standard Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, October 2004
Table of Contents
Table 5-62: Perry
Table 5-64: Porter
